Chao Hsiao-Yun, Liu Peng-Hui, Lin Shen-Che, Chen Chun-Kuei, Chen Jih-Chang, Chan Yi-Lin, Wu Chin-Chieh, Blaney Gerald N, Liu Zhen-Ying, Wu Cho-Ju, Chen Kuan-Fu
Department of Emergency Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
Department of Emergency Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.
PLoS One. 2017 Jan 20;12(1):e0170408. doi: 10.1371/journal.pone.0170408. eCollection 2017.
The associations between dysglycemia and mortality in septic patients with and without diabetes are yet to be confirmed. Our aim was to analyze the association of diabetes and sepsis mortality, and to examine how dysglycemia (hyperglycemia, hypoglycemia and glucose variability) affects in-hospital mortality of patients with suspected sepsis in emergency department (ED) and intensive care units.
Clinically suspected septic patients admitted to ED were included, and stratified into subgroups according to in-hospital mortality and the presence of diabetes. We analyzed patients' demographics, comorbidities, clinical and laboratory parameters, admission glucose levels and severity of sepsis. Odds ratio of mortality was assessed after adjusting for possible confounders. The correlations of admission glucose and CoV (blood glucose coefficients of variation) and mortality in diabetes and non-diabetes were also tested.
Diabetes was present in 58.3% of the patients. Diabetic patients were older, more likely to have end-stage renal disease and undergoing hemodialysis, but had fewer malignancies, less sepsis severity (lower Mortality in Emergency Department Sepsis Score), less steroid usage in emergency department, and lower in-hospital mortality rate (aOR:0.83, 95% CI 0.65-0.99, p = 0.044). Hyperglycemia at admission (glucose≥200 mg/dL) was associated with higher risks of in-hospital mortality among the non-diabetes patients (OR:1.83 vs. diabetes, 95% CI 1.20-2.80, p = 0.005) with the same elevated glucose levels at admission. In addition, CoV>30% resulted in higher risk of death as well (aOR:1.88 vs. CoV between 10 and 30, 95%CI 1.24-2.86 p = 0.003).
This study indicates that while diabetes mellitus seems to be a protective factor in sepsis patients, hyper- or hypoglycemia status on admission, and increased blood glucose variation during hospital stays, were independently associated with increased odds ratio of mortality.
血糖异常与合并或未合并糖尿病的脓毒症患者死亡率之间的关联尚未得到证实。我们的目的是分析糖尿病与脓毒症死亡率之间的关联,并研究血糖异常(高血糖、低血糖和血糖变异性)如何影响急诊科(ED)和重症监护病房疑似脓毒症患者的院内死亡率。
纳入入住ED的临床疑似脓毒症患者,并根据院内死亡率和糖尿病情况分层为亚组。我们分析了患者的人口统计学、合并症、临床和实验室参数、入院血糖水平以及脓毒症严重程度。在调整可能的混杂因素后评估死亡率的比值比。还测试了入院血糖和变异系数(血糖变异系数)与糖尿病和非糖尿病患者死亡率之间的相关性。
58.3%的患者患有糖尿病。糖尿病患者年龄更大,更有可能患有终末期肾病并接受血液透析,但恶性肿瘤较少,脓毒症严重程度较低(急诊脓毒症死亡率评分较低),急诊科使用类固醇较少,院内死亡率较低(校正后比值比:0.83,95%置信区间0.65 - 0.99,p = 0.044)。入院时高血糖(血糖≥200 mg/dL)与非糖尿病患者中较高的院内死亡风险相关(比值比:1.83对比糖尿病患者,95%置信区间1.20 - 2.80,p = 0.005),入院时血糖水平相同。此外,变异系数>30%也导致更高的死亡风险(校正后比值比:1.88对比变异系数在10%至30%之间,95%置信区间1.24 - 2.86,p = 0.003)。
本研究表明,虽然糖尿病似乎是脓毒症患者的一个保护因素,但入院时的高血糖或低血糖状态以及住院期间血糖变异性增加与死亡率比值比增加独立相关。